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A B S T R A C T
Locally infected wounds and wounds colonised with multidrug-resistant bacteria are commonly treated
with local antimicrobial agents. Recently, wound dressings have been introduced into clinical practice
that reduces bacteria by adsorbing bacteria on the dressing surface by a hydrophobic effect. Our aim was
to investigate, whether this hydrophobic effect is only present in dressings coated with dialkyl
carbamoyl chloride (DACC) or also in other modern wound dressings.
To determine the hydrophobicity of the dressing surface contact angle measurements were
performed. In addition, for selected wound dressings, the bacteria eliminating effect of the wound
dressings for Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa were
measured.
31 of the 34 wound dressings presented with a hydrophobic surface. The reduction factor (RF) of one
wound dressing without coating was 1.6 for MRSA and RF 2.1 for P. aeruginosa. One with a DACC coated
dressing showed a RF of 0.7 (MRSA) and 1.2 (P. aeruginosa). The RF of a wound dressing that releases
silver ions was 6.1 for MRSA and 7.5 for P. aeruginosa respectively.
The results show that both uncoated and with DACC coated wound dressings can have hydrophobic
surfaces. These hydrophobic dressings are able to adsorb bacteria onto their surface and consequently
remove them from the wound. However, the RF for wound dressings that release silver ions is
signiﬁcantly higher.
Depending on the degree of contamination, these results can have an effect on the clinical decision to
choose certain products. We assume that for e.g. infected or critically colonised wounds, wound
dressings with a hydrophobic effect may not be sufﬁcient to signiﬁcantly improve the microbiological
wound condition. However, this assumption has to be veriﬁed in clinical studies.
 2014 Elsevier GmbH. All rights reserved.
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The bacterial load of a chronic wound can be a signiﬁcant factor
for delayed healing [1]. In addition, there is a relation between the
concentration of the bacteria in the wound and the tendency of the
wound to heal [2].
In modern wound management, wounds with localised signs of
infection or a colonisation with multidrug-resistant organisms
(MDRO) are considered as an indicator for a local antimicrobial
therapy [3]. Active agents of choice are silver ions, polihexanide,
octenidine and povidone-iodine [3]. Recently, there are new
treatment options discussed using the hydrophobic effect that* Corresponding author. Tel.: +49 40 557631 0.
E-mail address: ﬂorian.b@brillhygiene.com (Florian H.H. Brill).
http://dx.doi.org/10.1016/j.wndm.2014.04.003
2213-9095/ 2014 Elsevier GmbH. All rights reserved.eliminates bacteria through adsorbing them into the wound
dressing [4]. Wound dressings coated with dialkyl carbomyl
chloride (DACC) are considered to have a strong bacteria-reducing
effect. The reason for this effect is that the DACC-coating increases
the hydrophobic characteristics of the dressing surface [5,6].
However, there are no studies available that show if this effect
does only work for DACC-coated wound dressings or also for other
modern wound dressings. Therefore, the aim of this study was to
measure the hydrophobic surface properties of 34 representatively
chosen wound dressings. In addition, we examined for selected
wound dressings with and without a DACC coating on their ability
to eliminate bacteria from agar surfaces in a quantitative in vitro
model. In addition, a wound dressing that releases silver ions was
included to evaluate if the hydrophobic effect can eliminate
bacteria as effectively as the silver ions due to the oligodynamic
effect [7,8].
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2.1. Determining of the hydrophobic surface
Contact angle measurement is a generally accepted method for
determining the hydrophobic effect of aqueous solutions on
surfaces [9]. If a surface shows a contact angle of around 908, it is
considered to have hydrophobic properties. To determine the
contact angle, a drop of aqueous artiﬁcial wound exudate was
placed [10] on the wound-facing side of the dressing. This drop was
photographed with a Canon EOS 400D using a normal lens (18–
55 mm) under standardised conditions (Fig. 1). The contact angle
was measured on a printout with a geometry set square. A
minimum of 3 and a maximum of 15 parallel measurements for
each wound dressing were performed and the average value,
median and standard deviation were calculated.
2.2. Determination antibacterial reduction factors
Agar plates were inoculated with 0.1 ml of a suspension
containing the test bacteria, then the circular wound dressing
specimen with a diameter of 20 mm were placed on top. After 24 h,
the qualitative antimicrobial effect was determined by measuring
the diameter of the zone of inhibition. To determine the
quantitative antimicrobial effect, the agar directly under the test
specimen (diameter 20 mm) was removed with an aqueous
neutraliser solution and homogenised in a Stomacher bag. The
neutraliser was validated in accordance with DIN EN 13727 [11].
From the homogenised suspension, the viable bacteria count was
determined on Trypticase Soy bean Agar (TSA). In parallel a control
study with cotton gauze soaked in water of standardised hardness
(WSH [11]) was conducted in the same way as described above [7].
All trials were performed with 10 parallels. The reduction factors
were calculated from the difference between the remaining
bacteria count at the end of the control study and remaining
count from the test series with the test specimen and calculated as
log10:
log10 colony-forming units ðCFUÞ=ml control study WSH
 log10 CFU=ml test specimen 1
¼ RF:
Test wound dressings:
 Biatain Ag 10 cm  10 cm, non-adhering foam dressing (Colo-
plast A/S, Humlebæk, Denmark, lot no. 2857610, expiry date May
2014).Fig. 1. The artiﬁcial wound exudate was applied with a pipette (1–2 ml) and directly
under standardised conditions photographed. Biatain 10 cm  10 cm, non-adhering foam dressing (Coloplast
A/S, Humlebæk, Denmark, lot no. 2904925, expiry date August
2014).
 Alione 10 cm  10 cm, hydro capillary wound dressing (Colo-
plast A/S, Humlebæk, Denmark, lot no. 3183838, expiry date
February 2015).
 Cutimed Sorbact 10 cm  10 cm bacteria-binding swabs (BSN
medical GmbH, Hamburg, Germany lot no. 038093, expiry date
October 2015).
 Cutimed Siltec Sorbact 12.5 cm  12.5 cm bacteria-binding foam
dressing with adhesive silicone edge and super-absorbents (BSN
medical GmbH, Hamburg, Germany, lot no. 22810741, expiry
date June 2015).
 Cotton gauze ES pads 10 cm  10 cm (autoclaved, Paul Hart-
mann AG, Heidenheim, Germany, lot no. 61007601).
Soaking liquid: WSH (Dr. Brill + Partner GmbH,
Hamburg)
Shape and size of the
test specimen:
circular, diameter: 20 mm.
Storage conditions: room temperature and darkness.
Culture mediums and
organic load:
TSA without organic load.
Test temperature: 36 8C
Contact time: 24 h
Incubation temperatures: 36 8C  1 8C.
Neutralisation medium: 30 g/L polysorbate 80, 30 g/L
saponine, 1 g/L histidine, 1 g/L
cysteine (TSHC).
Test organisms: Methicillin-resistant Staphylococcus
aureus (MRSA) ATCC 33952
Pseudomonas aeruginosa ATCC 15442
3. Results
3.1. Hydrophobic effect
The contact angle was determined for 34 different wound
dressings. An overview of the wound dressings and their main
characteristics (category, coating and active ingredient) can be
found in Table 1. With 1208, the greatest contact angle was
measured for the Cutimed Sorbact gauze swab. The smallest
contact angle, 718, was measured for Atrauman AG (Table 1).
Due to similar structural characteristics, the tested wound
dressings were grouped into eight different categories (Fig. 2):
 Polyurethane foam without active ingredients and without
surface coating.
 Polyurethane foam with active ingredients and without surface
coating.
 DACC without additional surface coating.
 Polyurethane foam without active ingredients but with silicone
coating.
 Polyurethane foam with active ingredients and with silicone
coating.
 DACC with additional surface coating.
 Polyurethane foam with DACC coating.
 Polyester-/polyamide ﬁbre with coating and polyurethane foam
with partial non-silicone adhesive layer.
All product categories have a contact angle of around 908. With
1118, the group of wound dressings with DACC and additional
Table 1
Mean and median values and standard deviation oft he measured contact angles for all tested wound dressings.
Product Manufacturer Type of dressing Mean SD Median SD
Acticoat Moisture Control Smith&Nephew GmbH Polyurethan foam dressing 10.52 9.23 109 9.23
Allevyn Silver Non-Adhesive Smith&Nephew GmbH Polyurethan foam dressing 10.07 7.09 100 7.09
Allevyn Silber Schaumverband haftend Smith&Nephew GmbH Polyurethan foam dressing 94.8 1.71 94.5 1.71
Allevyn Silber Schaumverband nicht haftend Smith&Nephew GmbH Polyurethan foam dressing 89.4 4.03 89 4.03
Allevyn Ag Gentle Smith&Nephew GmbH foam dressing 92.9 3.28 94 3.28
Allevyn Ag Gentle Border Smith&Nephew GmbH foam dressing 99.4 10.70 96 10.70
AMD Antimicrobial Foam Dressing Covidien Deutschland GmbH foam dressing 80.7 3.08 81.5 3.08
Atrauman Ag Paul Hartmann AG Polyamide 71.2 6.62 72 6.62
Biatain Ag Haftend Coloplast GmbH Polyurethan-foam dressing 83.9 6.16 84.5 6.16
Biatain Ag nicht-haftend Coloplast GmbH Polyurethan-foam dressing 78.4 4.03 78 4.03
Biatain Nicht-Haftend Coloplast GmbH Polyurethan-foam dressing 85.3 8.22 86 8.22
Biatain Haftend Coloplast GmbH Polyurethan-foam dressing 88.3 4.68 87 4.68
Biatain Sanft-Haftend Coloplast GmbH Polyurethan-foam dressing 91.5 3.10 92 3.10
Biatain Silicone Coloplast GmbH Polyurethan foam dressing 95.9 9.33 94 9.33
Biatain Silicone Ag Coloplast GmbH Polyurethan-foam dressing 83.8 6.91 84.5 6.91
Biatain Silicone Lite Coloplast GmbH Polyurethan foam dressing 95.3 5.68 97 5.68
Cutimed Siltec Sorbact BSN medical foam dressing, DACC 100.6 12.64 106 12.64
Cutimed Siltec BSN medical foam dressing, DACC 91.8 8.52 90.5 8.52
Cutimed Sorbact Tupfer BSN medical Acetate, DACC 82.0 24.27 69 24.27
Cutimed Sorbact Tamponade BSN medical Acetate, DACC 120.3 7.91 120 7.91
Cutimed Sorbact Saugkompresse BSN medical Acetate, DACC 90.9 2.23 90 2.23
Cutimed Sorbact Hydroactive Gel-Wundauﬂage BSN medical Acetate, DACC 107.1 10.29 105 10.29
Cutimed Sorbact Hydroactive B Gel-Wundauﬂage
mit Haftrand
BSN medical Acetate, DACC 114.9 8.84 116 8.84
Cutimed Siltec L Silikon Schaumverband BSN medical foam dressing, DACC 96.9 3.54 97 3.54
DracoFoam PHMB Dr. Ausbu¨ttel & Co. GmbH Polyurethan foam dressing 77.9 8.15 79 8.15
Mepilex Border Mo¨lnlycke Health Care GmbH Polyurethan foam dressing 105.8 7.27 104.5 7.27
MepilexBorder Lite Mo¨lnlycke Health Care GmbH Polyurethan foam dressing 100.3 12.47 101.5 12.47
Mepilex Border Ag Mo¨lnlycke Health Care GmbH Polyurethan foam dressing 100.2 7.56 98 7.56
Mepilex Ag Mo¨lnlycke Health Care GmbH Polyurethan foam dressing 115.7 11.76 116 11.76
Physiotulle Ag Coloplast GmbH Polyesterﬁber 101 5.90 100 5.90
Urgotul AG Lite Border Urgo Medical GmbH Polyesterﬁber 75.3 2.50 75.5 2.5
Urgocell AG Silver Border Urgo Medical GmbH Polyesterﬁber/polyurethancompress 94.3 5.09 95 5.09
Urgocell Silver AG Plata NA Urgo Medical GmbH Polyesterﬁber/polyurethancompress 96.4 5.89 95.5 5.89
Urgotul Silver AG Plata Urgo Medical GmbH Polyesterﬁber 101.5 6.66 103 6.66
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group of polyurethane foams without active ingredients and
without surface coating displays the smallest contact angle (Fig. 2;
Table 1).
3.2. Antimicrobial activity
In the qualitative agar diffusion test, only two of the ﬁve
samples tested developed a zone of inhibition. With an averageFig. 2. Means (blue) and medians (green) of measured contact angles with artiﬁcial woun
color in this ﬁgure legend, the reader is referred to the web version of the article.)diameter of 0.4 mm for MRSA and 0.2 mm for P. aeruginosa, the
zone of inhibition for Cutimed Siltec Sorbact was relatively small.
Indeed, an inhibition was only measurable in 4 out of 10 parallel
tests. The silver ions releasing wound dressing presented with a
stronger inhibition effect. In average, the zones of inhibition
measured were 2.1 mm (MRSA)/3.5 mm (P. aeruginosa). This effect
was visible in all 10 parallel tests (Table 2).
The quantitative results for the antibacterial effect for Alione
and Cutimed Sorbact similar log RF of approx. 0.5 for MRSA wered exudate in the different product categories. (For interpretation of the references to
Table 2
Means of inhibition zones in mm and standard deviation (SD) from qualitative agar
diffusion assay for MRSA and P. aeruginosa.
MRSA P. aeruginosa
Mean SD Mean SD
Biatain Ag 2.1 0.2 3.5 0.41
Biatain 0.0 0.0 0.0 0.00
Alione 0.0 0.0 0.0 0.00
Cutimed Sorbact 0.0 0.0 0.0 0.00
Cutimed Siltec Sorbact 0.4 0.5 0.2 0.27
Control (Gaze) 0.0 0.0 0.0 0.00
Table 3
Reduction factors (RF) from quantitative efﬁcacy testing against MRSA and P.
aeruginosa. Means of remaining colony forming units (cfu) and standard deviations
(SD) are presented.
MRSA P. aeruginosa
Mean log10 KBE
log10 cfu SD RF log10 cfu SD RF
Biatain Ag 1.9 0.66 6.8 0.0 0.00 8.7
Biatain 7.1 0.33 1.6 6.6 0.27 2.1
Alione 8.4 0.40 0.4 8.1 0.55 0.6
Cutimed Sorbact 8.8 0.28 0.1 8.8 0.37 0.1
Cutimed Siltec Sorbact 8.0 0.25 0.7 7.5 0.69 1.2
Control (Gaze) 8.7 0.57 0.5 8.7 0.88 0.9
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factors of log RF 1.6/6.8 were detected. In the case of P. aeruginosa,
comparable but higher RFs were measured (Fig. 3 and Table 3).
4. Discussion
The studies on the hydrophobicity of surfaces and on bacteria
elimination delivered some remarkable and surprising results. The
majority of the wound dressings tested presented a contact angle
of around 908 and consequently have a hydrophobic surface.
However, the differences between the individual product catego-
ries are statistically signiﬁcant (t-test, signiﬁcance level 5%, see
Table 1). The measurement uncertainty of the study method,
however, limits the statistical comparison. The drop of artiﬁcial
wound exudate applied to the different wound dressings isFig. 3. Reduction factors (RF) of different woundabsorbed with varying speed (initial absorption). However, the
method requires a drop on the surface before every measurement
(Fig. 1). Consequently, contact angle variations of below 108 do not
qualify as an actual difference. The studies nonetheless conﬁrm
that a DACC coating makes the surface of wound dressings strongly
hydrophobic [4–6]. However, the data also show that most other
modern wound dressings also have a hydrophobic surface.
The results of the qualitative agar diffusion tests were as
expected. Since only Biatain Ag releases an antimicrobial active
ingredient as anticipated, a zone of inhibition only formed here [7].
The present results on quantitative bacteria elimination are,
however, surprising. Our hypothesis was that the hydrophobic
effect of the DACC-coated foam wound dressings would cause a
quantitatively superior adsorption of bacteria compared to e.g. a
‘‘normal’’, uncoated standard polyurethane foam wound dressings.
A maximum RF of 0.7 (MRSA) or 1.2 for P. aeruginosa were detected
for the DACC-coated dressings. This conﬁrms published data on the
hydrophobic effect [5,6]. However, a higher RF of 1.6/log RF of 2.1
was detected for an uncoated polyurethane foam dressing.
This leads to the conclusion that there is no direct correlation
between the hydrophobicity of wound dressings and bacteria
elimination or adsorption. The uncoated polyurethane foam
wound dressing with a contact angle of 888 absorbed more
bacteria than the DACC-coated dressing with a contact angle of
1118. On the basis of these results, we can presume that in addition
to the hydrophobic interactions of the bacteria with the surface,
the exudate absorption capacity of the wound dressing and the size
of the bacteria-adsorbing available surface area seem to playing an
important role in passive bacteria elimination.
The test series on the silver-releasing wound dressing showed
that, as expected, the active elimination of the bacteria with an
antimicrobial active ingredient is signiﬁcantly more efﬁcient than
the passive elimination [7]. This difference can be demonstrated
very clearly when comparing the foam wound dressings Biatain
and Biatain Ag. The only difference between these foam dressings
is that Biatain Ag has been impregnated with silver ions. The
additional effect of the silver ions can be calculated and is above 5
log steps (100,000):
MRSA: 6.8 (RF Biatain Ag)  1.6 (RF Biatain) = 5.2 (log10
difference)
P. aeruginosa: 8.7 (RF Biatain Ag)  2.1 (RF Biatain) = 6.6 (log10
difference) dressings against MRSA and P. aeruginosa.
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The results show that wound dressings coated with DACC and
uncoated wound dressings can have a hydrophobic surface. These
products are able to adsorb bacteria onto their surface and
consequently eliminate them from the wound. However, the
antimicrobial effect of wound dressings that release an active
ingredient such as silver ions is signiﬁcantly higher.
These lab results cannot be transferred directly to the clinical
situation. However, they should be considered when choosing
products to treat wounds with a high bacterial load. We assume
that for e.g. infected or critically colonised wounds, wound
dressings with a hydrophobic effect may not be enough to
signiﬁcantly improve the microbiological wound condition.
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